Panacea Biotec Ltd receives LoA from UNICEF

Panacea Biotec Limited ("the Company") has received a Letter of Award from UNICEF for a Long-Term Agreement for supply of bivalent oral polio vaccine (bOPV) to UNICEF starting from 1st April 2026 to 31st March 2030.

The total award to the Company is for supply of bOPV in 10 and 20 vial presentation worth ~US$ 35.65 million (~Rs.315 Crore) for a period of Q2 CY2026 and CY2027.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 415.30 as compared to the previous close of Rs. 402.15. The total number of shares traded during the day was 39270 in over 2002 trades.

The stock hit an intraday high of Rs. 423.70 and intraday low of 399.00. The net turnover during the day was Rs. 16229658.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 Biotechnology LoA UNICEF bOPVSupply